to my point here is the sanofi/regn pr of their fa
Post# of 145639
can tell by reading this pr patients suffered by adverse effects[thank god for leronlimab].many surely died but the pr is cleverly worded to try to avoid the death issue.
https://www.sanofi.com/en/media-room/press-re...2-22-30-00
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)